Prospective preference assessment for the Comparison of Analgesic Regimen Effectiveness and Safety in Surgery (CARES) trial.
Brian HyungMark C BicketRichard BrullJanneth Pazmino-CanizaresDidem BozakKarim S LadhaPublished in: Trials (2022)
This PPA revealed that two key discouraging factors for patients were being blinded to the type of pain medication being taken and the potential for poor pain management as a consequence of participation. Modifications to improve patient acceptance of the CARES trial include ensuring sufficient rescue medicine and follow-up visits consistent with current standards of care for all patients, as well as patient education surrounding safe administration and side effects of the study medications.
Keyphrases
- pain management
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic pain
- chronic kidney disease
- clinical trial
- study protocol
- minimally invasive
- prognostic factors
- randomized controlled trial
- palliative care
- neuropathic pain
- spinal cord injury
- quality improvement
- risk assessment
- coronary artery bypass
- health insurance
- double blind